Oral Corticosteroids Use Patterns in Asthma GINA Steps 4 and 5 Patients in a US Commercially Insured Population

被引:0
|
作者
Hanania, N. A. [1 ]
Fang, J. [2 ]
Altman, P. [2 ]
Ortiz, B. [2 ]
Alvares, L. [3 ]
Zhou, L. [4 ]
Cao, H. [2 ]
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Novartis Pharma AG, Basel, Switzerland
[4] KMK Consulting LLC, Morristown, NJ USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1269
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Uncontrolled asthma across GINA treatment steps 2-5 in a large US patient cohort
    Busse, William W.
    Fang, Juanzhi
    Marvel, Jessica
    Tian, Hengfeng
    Altman, Pablo
    Cao, Hui
    [J]. JOURNAL OF ASTHMA, 2022, 59 (05) : 1051 - 1063
  • [22] "Patterns of opioid use in commercially insured cancer patients" (MM10)
    Fleming, Sean P.
    Le, Tham T.
    Simoni-Wastila, Linda
    [J]. ADDICTION SCIENCE & CLINICAL PRACTICE, 2020, 15 (SUPPL 2):
  • [23] Appropriate use of inhaled corticosteroid and long-acting β2-adrenergic agonist combination therapy among asthma patients in a US commercially insured population
    Ye, Xin
    Gutierrez, Benjamin
    Zarotsky, Victoria
    Nelson, Michael
    Blanchette, Christopher M.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (09) : 2251 - 2258
  • [24] Measuring Burden of Oral Corticosteroids in US and German Patients with Severe Asthma
    Hinds, D.
    Martin, S.
    Nelsen, L.
    Cockle, S.
    Clark, M.
    Evans, E.
    Albers, F. C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [25] Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population
    Kern, David M.
    Chang, Lawrence
    Sonawane, Kalyani
    Larmore, Cynthia J.
    Boytsov, Natalie N.
    Quimbo, Ralph A.
    Singer, Joseph
    Hinton, John T.
    Wu, Sze-jung
    Araujo, Andre B.
    [J]. RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 355 - 369
  • [26] Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population
    David M. Kern
    Lawrence Chang
    Kalyani Sonawane
    Cynthia J. Larmore
    Natalie N. Boytsov
    Ralph A. Quimbo
    Joseph Singer
    John T. Hinton
    Sze-jung Wu
    Andre B. Araujo
    [J]. Rheumatology and Therapy, 2018, 5 : 355 - 369
  • [27] Treatment situation of patients with uncontrolled GINA 4 or 5 asthma in Germany
    Timmermann, H.
    Milger, K.
    Virchow, J. C.
    Schmidt, O.
    Bergmann, K. C.
    Koschel, D.
    Neurohr, C.
    Scholz, F.
    Lindner, R.
    Heck, S.
    Skowasch, D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [28] FACTORS INFLUENCING THE USE OF MASTECTOMY AMONG WOMEN WITH BREAST CANCER IN A COMMERCIALLY INSURED US POPULATION
    Khanna, R.
    Kalsekar, I
    Bamow, A.
    Canfield, T.
    Liao, R.
    Yadalam, S.
    Alderman, A.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A125 - A125
  • [29] Asthma Outcomes in Pediatric Patients Utilizing XOLAIR (Omalizumab) in a Commercially Insured Population in the United States
    Sullivan, P.
    Ghaedsharaf, Y.
    Zheng, Z.
    Mumneh, N.
    Ndife, B.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [30] Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis
    Desai, Rishi J.
    Mahesri, Mufaddal
    Gagne, Joshua J.
    Hurley, Eimir
    Tong, Angela
    Chitnis, Tanuja
    Minden, Sarah
    Spettell, Claire M.
    Matlin, Olga S.
    Shrank, William H.
    Choudhry, Niteesh K.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (01): : 113 - 121